Redmond Asset Management, LLC Dyne Therapeutics, Inc. Transaction History

Redmond Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$6.62 - $13.64 $4,739 - $9,766	-716 Reduced 5.42%	12,500 $166,000
Q1 2023 May 03, 2023	SELL	$10.88 - $15.0 $1,196 - $1,650	-110 Reduced 0.83%	13,216 $152,000
Q4 2022 Feb 06, 2023	BUY	$9.37 - $13.8 $1,480 - $2,180	158 Added 1.2%	13,326 $154,000
Q3 2022 Nov 10, 2022	SELL	$7.2 - $15.17 $165 - $348	-23 Reduced 0.17%	13,168 $167,000
Q1 2022 May 03, 2022	BUY	$6.52 - $12.27 $3,481 - $6,552	534 Added 4.22%	13,191 $127,000
Q4 2021 Feb 04, 2022	BUY	$11.89 - $16.07 $1,712 - $2,314	144 Added 1.15%	12,657 $150,000
Q1 2021 May 06, 2021	BUY	$14.0 - $29.3 $175,182 - $366,630	12,513 New	12,513 $194,000

208

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $718M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.